The HER2-Positive Breast Cancer Market size is expected to grow at an annual average CAGR of 1% during 2022-2028. Human epidermal growth factor receptor 2 (HER2) is a gene involved in the development of breast cancer. Genes contain the recipes for many of the proteins cells need to stay healthy and function normally. This protein stimulates cancer cell proliferation. About 1 in 5 breast cancer cancer cells have an extra copy of the gene that produces the HER2 protein. Breast cancer that is HER2-positive is more aggressive than other types of breast cancer. Although anticancer drugs do not directly target the HER2 protein, certain regular chemotherapy treatments may be useful to treat HER2-positive breast tumors. Because results significantly influence treatment recommendations and decisions, experts advise testing for the presence of HER2 in all invasive breast cancers. Except as part of clinical trials, HER2 testing is not usually performed for ductal cancer in situ. If breast cancer recurs or expands, cancer cells should be re-examined for HER2 and hormone receptor status, which may change after the original diagnosis.
(Get 15% Discount on Buying this Report)
A full report of HER2-Positive Breast Cancer Market is available at: https://orionmarketreports.com/her2-positive-breast-cancer-market/86724/
The following segmentation are covered in this report:
By Application
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Treatment Type
- Chemotherapy
- Targeted Therapy Immunotherapy
- Others
Company Profile
- Roche (Genentech)
- AstraZeneca and
- Daiichi Sankyo
- Celgene
- Eisai
- Puma Biotechnology Novartis
- Macrogenics
- Seattle Genetics
- Jiangsu HengRui Medicine
The report covers the following objectives:
- Proliferation and maturation of trade in the global HER2-Positive Breast Cancer Market
- The market share of the global HER2-Positive Breast Cancer Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the HER2-Positive Breast Cancer Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global HER2-Positive Breast Cancer Market
Scope of the report
The research study analyses the HER2-Positive Breast Cancer Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by HER2-Positive Breast Cancer Market Report
- What was the HER2-Positive Breast Cancer Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
- What will be the CAGR of Market during the forecast period (2022-2028)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
- Which manufacturer/vendor/players in the HER2-Positive Breast Cancer Market was the market leader in 2022?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
